Advances in the Application and Impact of MicroRNAs As Therapies for Skin Disease

Overview

Journal BioDrugs

Specialties Allergy & Immunology
Genetics
Pharmacology

Date 2017 Sep 7

PMID 28875300

Citations 10

Authors

Paul Lawrence

Joseph Ceccoli

Affiliations

Soon will be listed here.

Abstract

The advent of RNA interference (RNAi) technology has profoundly impacted molecular biology research and medicine but has also advanced the field of skin care. Both effector molecules of RNAi, short-interfering RNA molecules and microRNAs (miRNAs), have been explored for their relative impact and utility for treating a variety of skin conditions. These post-transcriptional RNA regulatory molecules down-modulate protein expression through targeting of the 3' untranslated regions of messenger RNAs, leading to their degradation or repression through sequestration. As researchers hunt for genetic linkages to skin diseases, miRNA regulators have emerged as key players in the biology of keratinocytes, fibroblasts, melanocytes, and other cells of the skin. Herein, we attempt to coalesce the current efforts to combat various skin disorders and diseases through the development of miRNA-based technologies.

Citing Articles

Sele-targeted siRNA liposome nanoparticles inhibit pathological scars formation via blocking the cross-talk between monocyte and endothelial cells: a preclinical study based on a novel mice scar model.

Li L, Wang Y, Meng J, Wang X, Wu X, Wo Y J Nanobiotechnology. 2024; 22(1):733.

PMID: 39593088 PMC: 11600582. DOI: 10.1186/s12951-024-03003-4.

Splicing Modulation via Antisense Oligonucleotides in Recessive Dystrophic Epidermolysis Bullosa.

Hainzl S, Trattner L, Liemberger B, Bischof J, Kocher T, Ablinger M Int J Mol Sci. 2024; 25(2).

PMID: 38255836 PMC: 10815346. DOI: 10.3390/ijms25020761.

miRNome and Proteome Profiling of Human Keratinocytes and Adipose Derived Stem Cells Proposed miRNA-Mediated Regulations of Epidermal Growth Factor and Interleukin 1-Alpha.

Shahin H, Abdallah S, Das J, He W, El-Serafi I, Steinvall I Int J Mol Sci. 2023; 24(5).

PMID: 36902387 PMC: 10002856. DOI: 10.3390/ijms24054956.

Weekly treatment with SAMiRNA targeting the androgen receptor ameliorates androgenetic alopecia.

Yun S, Lee S, Goh E, Kwon O, Choi W, Kim J Sci Rep. 2022; 12(1):1607.

PMID: 35102171 PMC: 8803970. DOI: 10.1038/s41598-022-05544-w.

The role of microRNAs in diseases and related signaling pathways.

Vaghf A, Khansarinejad B, Ghaznavi-Rad E, Mondanizadeh M Mol Biol Rep. 2021; 49(7):6789-6801.

PMID: 34718938 DOI: 10.1007/s11033-021-06725-y.

References

Geusens B, Lambert J, De Smedt S, Buyens K, Sanders N, Van Gele M . Ultradeformable cationic liposomes for delivery of small interfering RNA (siRNA) into human primary melanocytes. J Control Release. 2008; 133(3):214-20. DOI: 10.1016/j.jconrel.2008.10.003. View

Kim V, Nam J . Genomics of microRNA. Trends Genet. 2006; 22(3):165-73. DOI: 10.1016/j.tig.2006.01.003. View

Lee G, Cha H, Lee K, Lee K, Hong J, Ahn K . Arctiin induces an UVB protective effect in human dermal fibroblast cells through microRNA expression changes. Int J Mol Med. 2014; 33(3):640-8. DOI: 10.3892/ijmm.2014.1616. View

Wang Y, Wang K, Liang J, Yang H, Dang N, Yang X . Differential expression analysis of miRNA in peripheral blood mononuclear cells of patients with non-segmental vitiligo. J Dermatol. 2014; 42(2):193-7. DOI: 10.1111/1346-8138.12725. View

Rock K, Tigges J, Sass S, Schutze A, Florea A, Fender A . miR-23a-3p causes cellular senescence by targeting hyaluronan synthase 2: possible implication for skin aging. J Invest Dermatol. 2014; 135(2):369-377. DOI: 10.1038/jid.2014.422. View

Bracke S, Desmet E, Guerrero-Aspizua S, Tjabringa S, Schalkwijk J, Van Gele M . Identifying targets for topical RNAi therapeutics in psoriasis: assessment of a new in vitro psoriasis model. Arch Dermatol Res. 2013; 305(6):501-12. DOI: 10.1007/s00403-013-1379-9. View

Chowdhari S, Saini N . hsa-miR-4516 mediated downregulation of STAT3/CDK6/UBE2N plays a role in PUVA induced apoptosis in keratinocytes. J Cell Physiol. 2014; 229(11):1630-8. DOI: 10.1002/jcp.24608. View

Borchard G . Chitosans for gene delivery. Adv Drug Deliv Rev. 2001; 52(2):145-50. DOI: 10.1016/s0169-409x(01)00198-3. View

Bernstein E, Caudy A, Hammond S, Hannon G . Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature. 2001; 409(6818):363-6. DOI: 10.1038/35053110. View

10.

Rebane A . microRNA and Allergy. Adv Exp Med Biol. 2015; 888:331-52. DOI: 10.1007/978-3-319-22671-2_17. View

11.

Seyhan A . RNAi: a potential new class of therapeutic for human genetic disease. Hum Genet. 2011; 130(5):583-605. DOI: 10.1007/s00439-011-0995-8. View

12.

Park S, Lee J, Ha M, Nam J, Kim V . miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42. Nat Struct Mol Biol. 2008; 16(1):23-9. DOI: 10.1038/nsmb.1533. View

13.

Kaban K, Salva E, Akbuga J . In Vitro Dose Studies on Chitosan Nanoplexes for microRNA Delivery in Breast Cancer Cells. Nucleic Acid Ther. 2016; 27(1):45-55. DOI: 10.1089/nat.2016.0633. View

14.

Sonkoly E, Stahle M, Pivarcsi A . MicroRNAs: novel regulators in skin inflammation. Clin Exp Dermatol. 2008; 33(3):312-5. DOI: 10.1111/j.1365-2230.2008.02804.x. View

15.

Faller M, Guo F . MicroRNA biogenesis: there's more than one way to skin a cat. Biochim Biophys Acta. 2008; 1779(11):663-7. PMC: 2633599. DOI: 10.1016/j.bbagrm.2008.08.005. View

16.

Xie M, Li M, Vilborg A, Lee N, Shu M, Yartseva V . Mammalian 5'-capped microRNA precursors that generate a single microRNA. Cell. 2013; 155(7):1568-80. PMC: 3899828. DOI: 10.1016/j.cell.2013.11.027. View

17.

Smith R, Warren R, Eyre S, Ho P, Ke X, Young H . Polymorphisms in the IL-12beta and IL-23R genes are associated with psoriasis of early onset in a UK cohort. J Invest Dermatol. 2007; 128(5):1325-7. DOI: 10.1038/sj.jid.5701140. View

18.

Crombez L, Aldrian-Herrada G, Konate K, Nguyen Q, McMaster G, Brasseur R . A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells. Mol Ther. 2008; 17(1):95-103. PMC: 2834975. DOI: 10.1038/mt.2008.215. View

19.

Rudzinski W, Aminabhavi T . Chitosan as a carrier for targeted delivery of small interfering RNA. Int J Pharm. 2010; 399(1-2):1-11. DOI: 10.1016/j.ijpharm.2010.08.022. View

20.

Cha H, Lee G, Lee K, Lee K, Hong J, Lee N . Photoprotective effect of arctiin against ultraviolet B-induced damage in HaCaT keratinocytes is mediated by microRNA expression changes. Mol Med Rep. 2014; 10(3):1363-70. DOI: 10.3892/mmr.2014.2326. View